AstraZeneca to buy California biotech firm TeneoTwo for up to $1.27 billion
July 05, 2022 at 10:31 AM EDT
The key asset to be acquired in the deal, which includes an $100 million upfront payment, is a new drug candidate that targets non-Hodgkin's lymphoma.
